Showing results (61-70 of 152) with videos related to
Sort By:
Pageof 16
Oncogene|August 4, 2015
Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1P Phatak, K A Byrnes, D Mansour, et al.The Cochrane Database of Systematic Reviews|July 22, 2004
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancyR French, H Van Vliet, F Cowan, et al.ESMO Open|July 11, 2022
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)S Rao, G Anandappa, J Capdevila, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|November 16, 2023
A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial DesignD C Gilbert, M Nankivell, H Rush, et al.The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomesJ L Morgan, A Shrestha, M W R Reed, et al.The British Journal of Surgery|March 24, 2021
Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choicesL Wyld, M W R Reed, K Collins, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.The European Physical Journal. C, Particles and Fields|August 5, 2017
Search for lepton-flavour-violating decays of the Higgs and Z bosons with the ATLAS detectorG Aad, B Abbott, J Abdallah, et al.The European Physical Journal. C, Particles and Fields|September 26, 2017
Performance of the ATLAS trigger system in 2015, M Aaboud, G Aad, et al.Pageof 16